Despite TMPRSS2 as well as ACE2 has higher expression levels after the onset of COVID-19 and cancers [45], no detailed study is available on their expression and interaction in cancer patients infected with COVID-19 or any other coronaviruses. Here, TMPRSS2 is linked to COVID-19.